Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

7.49
Delayed Data
As of 4:00pm ET
 -0.28 / -3.60%
Today’s Change
3.10
Today|||52-Week Range
13.40
-14.79%
Year-to-Date
New Strong Sell Stocks for July 20th
Jul 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close7.77
Today’s open7.78
Day’s range7.45 - 7.83
Volume3,731,750
Average volume (3 months)3,520,157
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-17.26%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.08-0.66%
GBTGlobal Blood Therape...-0.90-3.23%
INVAInnoviva Inc+0.49+3.71%
TXMDTherapeuticsMD Inc-0.48-8.14%
Data as of 6:30pm ET, 07/27/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts